If You Can’t Afford $4,500 Dollars, You’re Not Worth Saving, According to Big Pharma

There is no doubt that America is suffering a losing struggle with drugs. Ever since the war on drugs was announced in the nineteen-eighties, drug use, abuse, and overdose casualties have steadily increased.

Drugs have had a horrific effect on America and the entire world as a whole. Thousands of people lose their lives annually from overdosing on a variety of drugs. After the war on drugs was initiated the major problem drugs were the street drugs such as meth, heroin, or crack. However, as drug abuse steadily increases we are seeing a rise in prescription medication abuse and addiction. Every year hospitals around the country are filled with thousands of patients suffering from a lethal overdose of heroin – and the primary antidote just skyrocketed in price!

Since 2010, the amount of heroin overdose deaths has more than quadrupled annually. Heroin death rates went up 20.6% from 2015 to 2016. Close to 13,000 people died from overdosing on heroin in 2015, and it’s still only going up. In response to the opioid crisis, more than 40 states made Naloxone available without a prescription for the express purpose of family members being able to revive loved ones in case of an overdose. Narcan or Naloxone is the antidote for opioid overdose has been on the drug market since 1971 and was created generic in 1985.

However, things might’ve just gotten a bit harder for people to get to this essential antidote to a heroin overdose. The drug costs a reported $11.70 per 10 2ml bottles, as rated by the International Medical Product Guide. However, there’s a different case in the US now. In the United States one vial of Naloxone is 40 times the initial price of the drug. Creators and distributors of the famous EpiPen, not to mention that recent scandal, sell a bottle of naloxone at a whopping $23.72/ml!

In the pharmaceutical market, if you can’t afford a $4,500 dollar charge for a dose of medicine, well, you’re not worthy of life. Co-founder and CEO of Harm Reduction Therapeutics, Michael Hufford says, “philanthropic foundations backing this new nonprofit pharmaceutical model will help with an urgently needed response to the opioid crisis, while realizing a tremendous return on their investment, measured not in dollars, but in lives saved.”

Do you think we should do something about this by standing up to the big pharma? Certainly, all humans should be allowed a second chance… What if it were you, or a loved one?

image via

Leave a Reply